The main goal of pharmaceutical companies is to create and deliver medicines designed to extend or enhance life. However—also being in the business of business—pharmaceutical companies need to grow their bottom lines by investing in business value drivers. This article shows sustainability performance as one of those drivers by demonstrating that: 1) the concept of integrated sustainability is generally understood; and 2) pharmaceutical companies taking action to integrate sustainability are reaping significant business value added. Since there are currently no standardized methods of integrating, measuring, or communicating sustainability, pharmaceutical companies are relying on self-interpretations of voluntary initiatives to successfully integrate sustainability
